Biocompatible peptide-based hydrogels as nanocarriers for a new antitumoral drug

In this work, several new hydrogelators were developed, containing a Naproxen or a Naphthalene group. The ability of these hydrogels to act as nanocarriers for an antitumoral drug was investigated.

Detalhes bibliográficos
Autor principal: Hortelão, Ana C. L. (author)
Outros Autores: Hermenegildo, Bruno F. (author), Vilaça, Helena (author), Pereira, Goreti (author), Xu, Bing (author), Queiroz, Maria João R. P. (author), Martins, J. A. (author), Ferreira, Paula M. T. (author), Castanheira, Elisabete M. S. (author)
Formato: conferenceObject
Idioma:eng
Publicado em: 2014
Assuntos:
Texto completo:http://hdl.handle.net/1822/30743
País:Portugal
Oai:oai:repositorium.sdum.uminho.pt:1822/30743